Functional Status Predicts Delay to Radiation in Free Tissue Transfer for Head and Neck Cancer.
adjuvant therapy
free flap
free tissue transfer
functional status
socioeconomic status
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
08 Jul 2024
08 Jul 2024
Historique:
revised:
20
05
2024
received:
21
08
2023
accepted:
17
06
2024
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
8
7
2024
Statut:
aheadofprint
Résumé
Evaluate the effect of functional status and patient factors on delays in treatment with adjuvant therapy. Retrospective chart review (2020-2022) was conducted at a single tertiary referral center. Data were collected between January 2020 and October 2022, and 63 patients underwent free flap reconstructive surgery of the head and neck due to the presence of cancer and received adjuvant radiation therapy (RT). The main outcomes measured were Area Deprivation Index (ADI), Beale scores, distance to radiation center, functional status, patient demographics, gender, and length from surgery to initiation of RT. Of the 63 patients who were reviewed, the average age was 65.5 years old and 63.8% were male. The average ADI state score was 5.6 and the national percentile of 77.1. The average Beale score was 3.7. The average distance traveled was 101.1 miles. Thirty-five patients were living independently, 16 were living in assisted living or received home care, and 15 were dependent or lived in a nursing home. Mann-Whitney U analysis revealed a significant association of increasing levels of dependence to delays in treatment compared to on-time treatment (p = 0.002). The odds of treatment delay were increased almost 10-fold for every additional increase in dependency level (OR = 9.87, 95% CI = 1.42-68.83). Degree of dependent functional status correlates with delays in postoperative adjuvant RT in patients undergoing free tissue transfer for head and neck cancer. Preoperative risk stratification allows for physicians to address barriers to adjuvant therapy prior to delay. Level 3 Laryngoscope, 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60‐72. https://doi.org/10.1056/NEJMra1715715.
Yeh SA. Radiotherapy for head and neck cancer. Semin Plast Surg. 2010;24(2):127‐136. https://doi.org/10.1055/s-0030-1255330.
Graboyes EM, Halbert CH, Li H, et al. Barriers to the delivery of timely, guideline‐adherent adjuvant therapy among patients with head and neck cancer. JCO Oncol Pract. 2020;16(12):e1417‐e1432. https://doi.org/10.1200/OP.20.00271.
Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386‐396. https://doi.org/10.1016/j.mayocp.2015.12.017.
Loganadane G, Kann BH, Park HS, et al. Clinical outcomes of head and neck cancer patients who undergo resection, but forgo adjuvant therapy. Anticancer Res. 2019;39(9):4885‐4890. https://doi.org/10.21873/anticanres.13674.
Perlow HK, Ramey SJ, Cassidy V, et al. Disparities in adherence to head and neck cancer follow‐up guidelines. Laryngoscope. 2019;129(10):2303‐2308. https://doi.org/10.1002/lary.27676.
Lavaf A, Genden EM, Cesaretti JA, Packer S, Kao J. Adjuvant radiotherapy improves overall survival for patients with lymph node‐positive head and neck squamous cell carcinoma. Cancer. 2008;112(3):535‐543. https://doi.org/10.1002/cncr.23206.
Kao J, Lavaf A, Teng MS, Huang D, Genden EM. Adjuvant radiotherapy and survival for patients with node‐positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys. 2008;71(2):362‐370. https://doi.org/10.1016/j.ijrobp.2007.09.058.
Cramer JD, Speedy SE, Ferris RL, Rademaker AW, Patel UA, Samant S. National evaluation of multidisciplinary quality metrics for head and neck cancer. Cancer. 2017;123(22):4372‐4381. https://doi.org/10.1002/cncr.30902.
National Comprehensive Cancer Network. NCCN Guidelines Version 2.2020: Head and Neck Cancers. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
Cooper JS. Radiation therapy oncology group 9501/intergroup: postoperative concurrent radiotherapy and chemotherapy for high‐risk squamous‐cell carcinoma of the head and neck. N Engl J Med. 2004. PMID: 15128893;350:1937‐1944. https://doi.org/10.1056/NEJMoa032646.
Bernier J. European Organization for Research and Treatment of cancer trial 22931: postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004. PMID: 15128894;350:1945‐1952. https://doi.org/10.1056/NEJMoa032641.
Tam M, Wu SP, Gerber NK, et al. The impact of adjuvant chemoradiotherapy timing on survival of head and neck cancers. Laryngoscope. 2018;128(10):2326‐2332. https://doi.org/10.1002/lary.27152.
Lu Y, Gehr AW, Meadows RJ, et al. Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety‐net health system. BMC Cancer. 2022;22(1):593. https://doi.org/10.1186/s12885-022-09688-w.
Guttmann DM, Kobie J, Grover S, et al. National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival. Head Neck. 2018;40(6):1147‐1155. https://doi.org/10.1002/hed.25091.
Javed AA, Floortje van Oosten A, Habib JR, et al. A delay in adjuvant therapy is associated with worse prognosis only in patients with transitional circulating tumor cells following resection of pancreatic ductal adenocarcinoma. Ann Surg. 2022;277:866‐872. https://doi.org/10.1097/SLA.0000000000005710.
Chen MM, Harris JP, Orosco RK, Sirjani D, Hara W, Divi V. Association of time between surgery and adjuvant therapy with survival in oral cavity cancer. Otolaryngol Head Neck Surg. 2018;158(6):1051‐1056. https://doi.org/10.1177/0194599817751679.
Graboyes EM, Garrett‐Mayer E, Sharma AK, Lentsch EJ, Day TA. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017;123(14):2651‐2660. https://doi.org/10.1002/cncr.30651.
Graboyes EM, Kompelli AR, Neskey DM, et al. Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145(2):166‐177. https://doi.org/10.1001/jamaoto.2018.2716.
Tang A, Mittal A, Mooney CM, et al. Factors delaying chemotherapy in patients with breast cancer at a safety‐net hospital. J Natl Med Assoc. 2022;113(6):706‐712. https://doi.org/10.1016/j.jnma.2021.08.035.
Kind AJH, Buckingham W. Making neighborhood disadvantage metrics accessible: the neighborhood atlas. N Engl J Med. 2018;378:2456‐2458. https://doi.org/10.1056/NEJMp1802313 PMCID: PMC6051533. AND University of Wisconsin School of Medicine Public Health. 2015 Area Deprivation Index v2.0. Downloaded from https://www.neighborhoodatlas.medicine.wisc.edu/ May 23, 2019.
Roffman CE, Buchanan J, Allison GT. Charlson comorbidities index. J Physiother. 2016;62(3):171. https://doi.org/10.1016/j.jphys.2016.05.008.
Dayan GS, Bahig H, Johnson‐Obaseki S, et al. Oncologic significance of therapeutic delays in patients with oral cavity cancer . JAMA Otolaryngol Head Neck Surg. 2023;149(11):961‐969. https://doi.org/10.1001/jamaoto.2023.1936.
Sawaf T, Virgen CG, Renslo B, et al. Association of social‐ecological factors with delay in time to initiation of postoperative radiation therapy: a prospective cohort study [published online ahead of print, 2023 Apr 20]. JAMA Otolaryngol Head Neck Surg. 2023;e230308;149:477‐484. https://doi.org/10.1001/jamaoto.2023.0308.
Sykes KJ, Morrow E, Smith JB, et al. What is the hold up?‐mixed‐methods analysis of postoperative radiotherapy delay in head and neck cancer. Head Neck. 2020;42(10):2948‐2957. https://doi.org/10.1002/hed.26355.
Shew M, New J, Bur AM. Machine learning to predict delays in adjuvant radiation following surgery for head and neck cancer. Otolaryngol Head Neck Surg. 2019;160(6):1058‐1064. https://doi.org/10.1177/0194599818823200.
Bennett KM, Scarborough JE, Pappas TN, Kepler TB. Patient socioeconomic status is an independent predictor of operative mortality. Ann Surg. 2010;252(3):552‐558. https://doi.org/10.1097/SLA.0b013e3181f2ac64.
Reames BN, Birkmeyer NJO, Dimick JB, Ghaferi AA. Socioeconomic disparities in mortality after cancer surgery: failure to rescue. JAMA Surg. 2014;149:475‐481.
Konradsen AA, Lund CM, Vistisen KK, Albieri V, Dalton SO, Nielsen DL. The influence of socioeconomic position on adjuvant treatment of stage III colon cancer: a systematic review and meta‐analysis. Acta Oncol. 2020;59(11):1291‐1299. https://doi.org/10.1080/0284186X.2020.1772501.
Marcotte LM, Krimmel‐Morrison J, Liao JM. How to keep diffusion of responsibility from undermining value‐based care. AMA J Ethics. 2020;22(9):E802‐E807. Published 2020 Sep 1. https://doi.org/10.1001/amajethics.2020.802.
Hanika C, Porter N, Blick K, Mendis J. Lifestyle choices following head and neck cancer treatment: a qualitative study. Nutr Health. 2024;30(1):175‐185. https://doi.org/10.1177/02601060221106624.
Sindhar S, Kallogjeri D, Wildes TS, Avidan MS, Piccirillo JF. Association of preoperative functional performance with outcomes after surgical treatment of head and neck cancer: a clinical severity staging system. JAMA Otolaryngol Head Neck Surg. 2019;145(12):1128‐1136. https://doi.org/10.1001/jamaoto.2019.1035.
Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope. 2000;110(4):593‐602. https://doi.org/10.1097/00005537-200004000-00011.
Davis KP, Kompelli A, Gardner JR, et al. Postoperative and 1‐year functional outcomes after free flap surgery among patients 80 years or older. Otolaryngol Head Neck Surg. 2022;167(1):41‐47. https://doi.org/10.1177/01945998221083592.
Lewis S, Pandey S, Salins N, et al. Distress screening in head and neck cancer patients planned for cancer‐directed radiotherapy. Laryngoscope. 2021;131(9):2023‐2029. https://doi.org/10.1002/lary.29491.
Lawrence LA, Heuermann ML, Javadi P, Sharma A. Socioeconomic status and rurality among patients with head and neck cancer. Otolaryngol Head Neck Surg. 2022;166(6):1028‐1037. https://doi.org/10.1177/01945998211019278.
de Jager E, Gunnarsson R, Ho YH. Disparities in surgical outcomes for low socioeconomic status patients in Australia. ANZ J Surg. 2022;92(5):1026‐1032. https://doi.org/10.1111/ans.17675.
Caudell JJ, Hamilton RD, Otto KJ, Jennelle RL, Pitman KT, Vijayakumar S. Induction docetaxel, cisplatin, and 5‐fluorouracil precludes definitive chemoradiotherapy in a substantial proportion of patients with head and neck cancer in a low socioeconomic status population. Am J Clin Oncol. 2014;37(4):332‐336. https://doi.org/10.1097/COC.0b013e31827a7cff.
Farquhar DR, Lenze NR, Masood MM, et al. Access to preventive care services and stage at diagnosis in head and neck cancer. Head Neck. 2020;42(10):2841‐2851. https://doi.org/10.1002/hed.26326.